Suppr超能文献

外显子组测序在一名具有与科妮莉亚·德·朗格综合征重叠特征的患者中鉴定出一种新的EP300移码突变。

Exome sequencing identifies a novel EP300 frame shift mutation in a patient with features that overlap Cornelia de Lange syndrome.

作者信息

Woods Susan A, Robinson Haynes B, Kohler Lisa J, Agamanolis Dimitris, Sterbenz George, Khalifa Mohamed

机构信息

Department of Genetics, Akron Children's Hospital, Akron, Ohio.

出版信息

Am J Med Genet A. 2014 Jan;164A(1):251-8. doi: 10.1002/ajmg.a.36237. Epub 2013 Oct 29.

Abstract

Rubinstein-Taybi syndrome (RTS) and Cornelia de Lange syndrome (CdLS) are genetically heterogeneous multiple anomalies syndromes, each having a distinctive facial gestalt. Two genes (CREBBP and EP300) are known to cause RTS, and five (NIPBL, SMC1A, SMC3, RAD21, and HDAC8) have been associated with CdLS. A diagnosis of RTS or CdLS is molecularly confirmed in only 65% of clinically identified cases, suggesting that additional causative genes exist for both conditions. In addition, although EP300 and CREBBP encode homologous proteins and perform similar functions, only eight EP300 positive RTS patients have been reported, suggesting that patients with EP300 mutations might be escaping clinical recognition. We report on a child with multiple congenital abnormalities and intellectual disability whose facial features and complex phenotype resemble CdLS. However, no mutations in CdLS-related genes were identified. Rather, a novel EP300 mutation was found on whole exome sequencing. Possible links between EP300 and genes causing CdLS are evident in the literature. Both EP300 and HDAC8 are involved in the regulation of TP53 transcriptional activity. In addition, p300 and other chromatin associated proteins, including NIPBL, SMCA1, and SMC3, have been found at enhancer regions in different cell types. It is therefore possible that EP300 and CdLS-related genes are involved in additional shared pathways, producing overlapping phenotypes. As whole exome sequencing becomes more widely utilized, the diverse phenotypes associated with EP300 mutations should be better understood. In the meantime, testing for EP300 mutations in those with features of CdLS may be warranted.

摘要

鲁宾斯坦-泰比综合征(RTS)和科妮莉亚·德·朗格综合征(CdLS)是具有遗传异质性的多发畸形综合征,每种综合征都有独特的面部特征。已知有两个基因(CREBBP和EP300)可导致RTS,五个基因(NIPBL、SMC1A、SMC3、RAD21和HDAC8)与CdLS相关。在临床确诊的病例中,仅有65%通过分子检测确诊为RTS或CdLS,这表明这两种病症可能还存在其他致病基因。此外,尽管EP300和CREBBP编码同源蛋白并执行相似功能,但仅有8例EP300阳性的RTS患者被报道,这表明携带EP300突变的患者可能未被临床识别。我们报告了一名患有多种先天性异常和智力残疾的儿童,其面部特征和复杂表型类似于CdLS。然而,未在CdLS相关基因中发现突变。相反,在全外显子组测序中发现了一个新的EP300突变。文献中明显显示了EP300与导致CdLS的基因之间可能存在的联系。EP300和HDAC8都参与TP53转录活性的调节。此外,已在不同细胞类型的增强子区域发现p300和其他与染色质相关的蛋白,包括NIPBL、SMCA1和SMC3。因此,EP300和CdLS相关基因可能参与其他共同途径,从而产生重叠的表型。随着全外显子组测序的更广泛应用,与EP300突变相关的多样表型应能得到更好的理解。与此同时,对具有CdLS特征的患者进行EP300突变检测可能是必要的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验